F703:XETRA:XETRA-Lyxor Portfolio Strategy Offensiv UCITS ETF (Vermoegensstrategie) (EUR)

ETF | Others |

Last Closing

USD 156.26

Change

-0.98 (-0.62)%

Market Cap

USD 0.02B

Volume

464.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.15 (-0.33%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.40 (-0.41%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.08 (-0.32%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.07 (-0.53%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.02 (-0.37%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.12 (-0.52%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.08 (-0.60%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.62 (+1.16%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.02 (-0.21%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.03 (+0.02%)

USD 12.26B

ETFs Containing F703:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.47% 72% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.47% 73% C 66% D+
Trailing 12 Months  
Capital Gain 9.44% 70% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.44% 71% C- 67% D+
Trailing 5 Years  
Capital Gain 82.25% 54% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.25% 55% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 8.26% 56% F 56% F
Dividend Return 9.75% 61% D- 60% D-
Total Return 1.50% 82% B 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 11.99% 53% F 62% D
Risk Adjusted Return 81.38% 70% C- 74% C
Market Capitalization 0.02B 15% F 12% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.